Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-047649

Chief Scientific Officer sold 11,685 shares at an average $37.47 ($437,885)

  • Chief Scientific Officer acquired 11,685 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-07-19 Option exercise +3,895 $6.32 $24,616 73,255 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-19 Sale −1,273 $36.70 $46,719 71,982 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-19 Sale −2,622 $37.33 $97,879 69,360 D: show line 3 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-20 Option exercise +3,895 $6.32 $24,616 73,255 D: show line 4 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-20 Sale −1,300 $36.81 $47,853 71,955 D: show line 5 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-20 Sale −2,595 $37.82 $98,143 69,360 D: show line 6 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-21 Option exercise +3,895 $6.32 $24,616 73,255 D: show line 7 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-21 Sale −1,400 $37.29 $52,206 71,855 D: show line 8 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-21 Sale −2,495 $38.11 $95,084 69,360 D: show line 9 in the form
Open-market sales · 11,685 sh · avg $37.47 · $437,885

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-07-19 Option exercise · Stock Option (Right to Buy) −3,895 112,955 D: show line 10 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-20 Option exercise · Stock Option (Right to Buy) −3,895 109,060 D: show line 11 in the form
ROBINS HARLAN S Chief Scientific Officer 2021-07-21 Option exercise · Stock Option (Right to Buy) −3,895 105,165 D: show line 12 in the form
Loading xslF345X03/doc4.xml…